Lv61
1824 积分 2023-10-18 加入
Discovery of 4-((2 S ,4 S )-4-Ethoxy-1-((5-methoxy-7-methyl-1 H -indol-4-yl)methyl)piperidin-2-yl)benzoic Acid (LNP023), a Factor B Inhibitor Specifically Designed To Be Applicable to Treating a Diverse Array of Complement Mediated Diseases
25天前
已完结
AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
3个月前
已完结
Discovery and Optimization of Hsp110 and sGC Dual-Target Regulators for the Treatment of Pulmonary Arterial Hypertension
6个月前
已完结
An Intravenous Study with the Radiolabeled sGC Stimulator Frespaciguat to Assess PK, Metabolism, and Mass Balance
6个月前
已完结
Unraveling the Role of Linker Design in Proteolysis Targeting Chimeras
6个月前
已完结
Structural pharmacology and mechanisms of GLP-1R signaling
8个月前
已完结
Development of the First Small-Molecule Inhibitor Targeting Oncostatin M for Treatment of Breast Cancer
9个月前
已完结
Sebetralstat (KVD900): A Potent and Selective Small Molecule Plasma Kallikrein Inhibitor Featuring a Novel P1 Group as a Potential Oral On-Demand Treatment for Hereditary Angioedema
9个月前
已完结
皖公网安备34019202002308
